montelukast


Also found in: Medical, Wikipedia.
Related to montelukast: Montelukast sodium, Singulair

mon·te·lu·kast

 (mŏn′tə-lo͞o′kăst)
n.
A drug that reduces the inflammatory response by acting as a leukotriene receptor antagonist, and is used to treat the signs and symptoms of asthma.

[monte-, of unknown origin + -lukast, leukotriene receptor antagonist suff.; see zafirlukast.]
Translations

montelukast

n montelukast m
References in periodicals archive ?
Montelukast (10 mg/kg) treatment showed significant (p < 0.05) decrease in peribronchial and perivascular inflammatory infiltration as compared to AR control mice (Fig.
M2 PHARMA-December 18, 2017-IntelGenx Corp receives approval from Health Canada for clinical trial application for Montelukast VersaFilm
M2 EQUITYBITES-December 18, 2017-IntelGenx Corp receives approval from Health Canada for clinical trial application for Montelukast VersaFilm
It was reported that rotenone--used in generating animal models of Parkinson's disease (PD)--increased CysLTR-1 expression in mouse microglial BV2 cell line [47,48] and that treatment with the CysLTR-1 antagonist montelukast prevented phagocytosis and cytokine release [48].
Objective: To evaluate and compare the protective effects of salbutamol and montelukast in amelioration of insulin induced airway hyper-reactivity on isolated tracheal smooth muscle of guinea pig in vitro.
His previous medications oral cetirizine 10 mg/day in morning and hydroxyzine 25 mg/day in evening along with montelukast sodium 10 mg/day along with xylometazoline nasal drops were continued.
Although LTD4 (a [CysLT.sub.1] receptor agonist) facilitates pentylenetetrazol (PTZ)-induced seizures, intracerebroventricular (icv) injection of montelukast (a [CysLT.sub.1] receptor inverse agonist) decreases PTZ-induced seizures.
16 -- Ajanta Pharma USA Inc., a subsidiary of Ajanta Pharma Limited, announced today the launch of Montelukast Sodium Oral Granules (4mg), a bioequivalent generic version of SINGULAIR(R) Granules, in the US market.
Montelukast is a leukotriene receptor (CysLT1) antagonist when administered orally is effective in the management of chronic asthma.
has added montelukast sodium tablets to its portfolio of products.
All subjects were provided with a standardized triple-drug therapy (cetirizine, ranitidine and montelukast) and a written action plan.